Boston Scientific (BSX)

Cost of Revenue

$1.59B

Quarterly · Period ending: · USD

BSX logo

BSX Cost of Revenue

Latest reported$1.59B
BSX Quarterly Cost of Revenue ($0.00 → $1.59B)
High-resolution chart · PNG

BSX cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Boston Scientific Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
1,594,000,000
1,590,000,000
1,348,000,000
1,523,000,000
1,637,000,000
1,713,000,000
1,890,000,000
1,561,000,000
1,535,000,000
1,472,000,000
1,413,000,000
1,360,000,000
1,323,000,000
1,312,000,000
1,287,000,000
1,242,000,000
1,256,000,000
1,183,000,000
1,186,000,000
1,100,000,000
1,135,000,000
1,085,000,000
1,207,000,000
1,086,000,000
1,016,000,000
1,030,000,000
1,078,000,000
977,000,000
935,000,000
899,000,000
885,000,000
808,000,000
860,000,000
791,000,000
800,000,000
779,000,000
789,000,000
803,000,000
760,000,000
743,000,000
659,000,000
592,000,000
590,000,000
556,000,000
558,000,000
537,000,000
584,000,000
571,000,000
588,000,000
577,000,000
579,000,000
538,000,000
577,000,000
619,000,000
611,000,000
558,000,000
578,000,000
631,000,000
660,000,000
680,000,000
688,000,000
631,000,000
660,000,000
623,000,000
654,000,000
663,000,000
709,000,000
629,000,000
630,000,000
607,000,000
630,000,000
655,000,000
604,000,000
580,000,000
636,000,000
575,000,000
563,000,000
568,000,000
526,000,000
630,000,000
677,000,000
374,000,000
342,000,000
343,000,000
357,000,000
344,000,000
328,000,000
309,000,000
363,000,000
292,000,000
257,000,000
243,000,000
235,000,000
226,000,000
227,000,000
211,000,000
225,000,000
207,000,000
215,000,000
214,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.